/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/4843x1496/b9b684dbb2/eapc-acronym-name-rgb.png)
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Predictors of kidney-related outcomes in chronic heart failure patients with concomitant type 2 diabetes mellitus treated with dapagliflozin
Event: Heart Failure 2024
Topic: Biomarkers
Session: ePosters in chronic heart failure - diagnostic methods
Low levels of irisin predicted worsening kidney function in dapagliflozin-treated patients with chronic heart failure and concomitant type 2 diabetes mellitus
Event: Heart Failure 2024
Topic: Biomarkers
Session: Chronic heart failure - biomarkers 3
Circulating levels of erythrocytes-derived vesicles related to poor glycaemia control in heart failure patients with type 2 diabetes mellitus
Event: Heart Failure 2024
Topic: Biomarkers
Session: Chronic heart failure - biomarkers 2
Predictors of worsening kidney function and their relation to SGLT2 inhibitor dapagliflozin administration in type 2 diabetes mellitus patients with chronic heart failure
Event: ESC Preventive Cardiology 2024
Topic: Biomarkers
Session: Managing risk in the cardio-renal continuum
Circulating Levels of erythrocytes-derived vesicles are associated with glucose control in type 2 diabetes mellitus patients with atrial fibrillation
Event: ESC Preventive Cardiology 2024
Topic: Diagnostic Methods
Session: Understanding cardiovascular risk development: novel mechanisms (1)
Low serum irisin levels predicted newly atrial fibrillation in patients with any phenotypes of chronic heart failure
Event: EHRA 2024
Topic: Clinical
Session: Congenital
Circulating levels of erythrocytes-derived vesicles related to poor glycaemia control in type 2 diabetes mellitus patients with atrial fibrillation
Event: EHRA 2024
Topic: Arrhythmias
Session: Miscellaneous 2
Low irisin levels predict acutely decompensated heart failure in type 2 diabetes mellitus patients
Event: ESC Acute CardioVascular Care 2024
Topic: Biomarkers
Session: Acute heart failure
The effect of sglt-2 inhibitor dapagliflozin on adropin serum levels in patients with chronic heart failure and concomitant type 2 diabetes mellitus
Event: ESC Congress 2023
Topic: Pharmacotherapy
Session: More insights into SGLT2i in heart failure
Altered myokine profile and glycemic control in type 2 diabetes mellitus patients with heart failure
Event: Heart Failure 2023
Topic: Biomarkers
Session: Chronic heart Failure - biomarkers 2
- …
